Trial intelligence / Profile preview

Foster versus Seretide Diskus for maintenance of asthma control in controlled adults with asthma

NL-OMON33799Phase 4Active, not recruiting

Sponsor
Chiesi Farmaceutici S.p.A.
Start
May 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in asthma comparing Foster with Seretide Diskus (2 arms). Primary endpoint: Pre-dose morning forced expiratory volume in one second (FEV1) at last clinic visit. Started May 2009; status: active, not recruiting.

02

Drugs

beclometasone dipropionate + formoterolsalmeterol + fluticasone
03

Conditions

asthma

Beyond the preview

Go deeper on NL-OMON33799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call